Gene Sequencing, Immune Response and Trials - Clinical Research Informer

Zynteglo halt re-ignites viral vector safety concerns; analysts

pharmaphorum

FEBRUARY 22, 2021

Bluebird Bio’s decision to hit pause on the launch of Zynteglo for beta thalassaemia after two cases of cancer were seen in a clinical trial could see fears over the safety of viral vectors used to deliver gene therapies resurface. . million in Europe.

Gene Therapy

Gene Therapy Gene Gene Sequencing Gene Expression

Medicago, GSK’s plant-made COVID jab clears phase 2

pharmaphorum

MAY 18, 2021

Canadian biotech Medicago has the data it was hoping for from a phase 2 trial of its COVID-19 vaccine, partnered with GlaxoSmithKline, and is now hoping to have phase 3 data available “by early summer.” The purified vaccine is administered alongside GSK’s pandemic adjuvant to boost the immune response.

Vaccination

Vaccination Vaccine Immune Response Gene Sequencing

Clinical Research Informer

Zynteglo halt re-ignites viral vector safety concerns; analysts

Medicago, GSK’s plant-made COVID jab clears phase 2

Webinars

Stay Connected